Reconstitution (Paclitaxel 01)
Paclitaxel Injection, Powder, Lyophilized, For Suspension
Product Images NDC 0781-3531
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 0781-3531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structure (Paclitaxel 02)
Vial Label (Paclitaxel 03)
This is a description of a drug called Paclitaxel, which is a cytotoxic agent used for intravenous (IV) administration. The medication is available as a sterile lyophilized powder for reconstitution. Each vial contains 100 mg of paclitaxel protein-bound along with approximately 900 mg of albumin. It is essential to store the reconstituted suspension in the original carton at 2° to 8°C and use it within 24 hours. The usual dosage and administration instructions can be found in the package insert. It is manufactured in China by Jiangsu Hengrui Pharmaceuticals Co. The drug's functional properties are specific to this formulation, so it should not be substituted with other paclitaxel products.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
